Eric Weisblum - Jun 17, 2022 Form 4 Insider Report for Silo Pharma, Inc. (SILO)

Role: CEO, CFO and President, Director
Signature: /s/ Eric Weisblum
Stock symbol: SILO
Transactions as of: Jun 17, 2022
Transactions value $: $1,500
Form type: 4
Date filed: 6/21/2022, 08:05 AM
Previous filing: Dec 15, 2021
Next filing: Dec 15, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SILO	Common Stock	Purchase	$1.5K	+13.1K	+0.17%	$0.11	7.72M	Jun 17, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1302 to $0.11. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1302 to $0.11. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.